Additional studies with catL inhibitor (Clik148) in a model of cyclophosphamide-induced diabetes in NOD mice confirmed the genetic knockout studies indicating that specific inhibition of this protease affords strong protection from disease and insulitis, albeit via a mechanism that may not involve Treg cells. The gene discussed is CTSL; the disease is diabetes mellitus.